Loading company…
Riskpilot
← Back to search
Sign in
Get full access
JAN BYE AS
AS
Active
Org 846956662
Slettaveien 23, 1553 Son
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 1988
3 employees
www.janbye.no
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 5,7M
-12% vs 2024
EBITDA margin
-0.6%
-106% vs 2024
Equity ratio
80.8%
Financial strength
Net profit 2025
NOK -232K
-188% vs 2024
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
NOK 5,7M
-12%
EBITDA
NOK -31K
-106%
Net profit
NOK -232K
-188%
Total assets
NOK 3,1M
-14%
Equity
NOK 2,5M
-8%
Employees
3
—
Company information
Legal name
JAN BYE AS
Org number
846956662
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26. april 1988
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Contact
Address
Slettaveien 23, 1553 Son
Website
www.janbye.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Vestby
All Norway companies
Revenue
NOK millions
0M
2M
4M
6M
8M
7M
2021
6M
2022
7M
2023
6M
2024
6M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
6 871
5 982
7 074
6 417
5 650
Staff expenses
−2 679
−2 355
−2 277
−2 454
−2 422
EBITDA
939
661
642
560
−31
Depreciation & amort.
−33
−207
−207
−207
−207
EBIT
906
454
435
353
−239
Net financials
−3
−70
−78
3
7
Profit before tax
903
383
357
355
−232
Tax
148
84
79
90
−0
Net profit
755
299
278
265
−232
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
3 257
3 323
3 420
3 647
3 120
Equity
1 910
2 209
2 487
2 752
2 520
Long-term debt
79
49
47
0
0
Short-term debt
1 268
1 065
887
895
600
Total debt
1 347
1 114
933
895
600
Financial ratios
5-year trend
EBITDA margin
-0.6%
This company
15.8%
Market median
-104% vs market
2021
2025
Equity ratio
80.8%
This company
38.2%
Market median
+112% vs market
2021
2025
Return on equity
-9.2%
This company
18.4%
Market median
-150% vs market
2021
2025
Net profit margin
-4.1%
This company
8.1%
Market median
-151% vs market
2021
2025
Asset turnover
1.81×
This company
1.12×
Market median
+62% vs market
2021
2025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PK
Per Kåre Finstad Bye
Chief Executive Officer
Chief Executive Officer
2016
TK
Tordis Kristin Finstad
Deputy Member
Deputy Member
1989
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
JB
Jan Bye
Chairman
1989
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of JAN BYE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Per Kåre Finstad Bye
Chief Executive Officer
0 companies
Tordis Kristin Finstad
Deputy Member
0 companies
Jan Bye
Chairman
0 companies